Pricing Log in Create free account
Friday 6 November 2026 Export BCRX’s income statement to Excel — free account

BioCryst Pharmaceuticals, Inc.

BCRX Healthcare Drug Manufacturers Specialty & Generic

BioCryst Pharmaceuticals, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $874.8 million, up 94.1% from fiscal 2024.

Revenue
+13.1%
EPS
+150.0%
Free cash flow
−18.7%
Total debt
+15.2%

Quarter to September 2026, against a year earlier

7.55 0.69 −8.37%
Market cap
$2.0B
P/E
0.0×
Fwd P/E
−3.7×
Dividend yield
—
F-score
7/9
Altman Z
1.83
Beneish M
−2.27
Dividend safety
n/a
Overview
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios

BioCryst Pharmaceuticals, Inc. (BCRX) Current ratio

Alert me on Current ratio

BioCryst Pharmaceuticals, Inc.'s current ratio at the end of the quarter to 30 September 2026 was 2.7×, up 0.6× from fiscal 2025 (2.1×). Over the past ten years it has ranged from 1.0× (fiscal 2015) to 5.5× (fiscal 2021); the current reading is higher than 55% of that period. That is above the Drug Manufacturers Specialty & Generic industry median of 2.4× and below the Healthcare sector median of 3.1×.

Current ratio, annual

Embed this chart

Annual newest first

Period Current ratio Change
FY2025 2.1× (21.62%)
FY2024 2.6× (20.43%)
FY2023 3.3× (32.45%)
FY2022 4.9× (10.32%)
FY2021 5.5× 78.11%
FY2020 3.1× 72.18%
FY2019 1.8× 8.14%
FY2018 1.6× (1.77%)
FY2017 1.7× 35.97%
FY2016 1.2× 20.26%

Quarterly newest first

Period Current ratio Change
Sep 2026 2.7× 16.87%
Jun 2026 2.3× 21.37%
Mar 2026 1.9× (7.28%)
Dec 2025 2.1× 10.30%
43 more quarters

Against its own ten years

Low 1.0× High 5.5×
Ten-year median 2.1×
Current reading's percentile 55

Current ratio against peers

Company Current ratio
RGC Regencell Bioscience Holdings Limited compare 10.8×
HCM HUTCHMED (China) Limited Sponsored ADR compare 5.6×
TRLV Trulieve Cannabis Corp. compare 5.5×
PBH Prestige Consumer Healthcare Inc. compare 2.9×
ANIP ANI Pharmaceuticals, Inc. compare 2.7×
BCRX BioCryst Pharmaceuticals, Inc. 2.7×
PRGO Perrigo Company plc compare 2.4×
XERS Xeris Biopharma Holdings, Inc. compare 2.2×
ALVO Alvotech compare 1.6×
Drug Manufacturers Specialty & Generic industry median 2.4×
Healthcare sector median 3.1×
Market median 1.6×

What Current ratio is

Current Ratio shows whether a company’s short-term assets are enough to cover the bills and debts it must pay within the next year.

Current Assets (Total) ÷ Current Liabilities (Total)

The full definition of Current ratio →

More on BCRX